UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000839
Receipt number R000001007
Scientific Title Randomized, double-blind, placebo-controlled crossover study of ejaculatory disorder caused by orally administered silodosin in healty volunteer men
Date of disclosure of the study information 2007/10/01
Last modified on 2008/04/10 00:27:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized, double-blind, placebo-controlled crossover study of ejaculatory disorder caused by orally administered silodosin in healty volunteer men

Acronym

Crossover study of ejaculatory disorder caused by silodosin

Scientific Title

Randomized, double-blind, placebo-controlled crossover study of ejaculatory disorder caused by orally administered silodosin in healty volunteer men

Scientific Title:Acronym

Crossover study of ejaculatory disorder caused by silodosin

Region

Japan


Condition

Condition

Japanese healthy volunteer men

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the quality of orgasm with and without ejaculatory disorder

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase IV


Assessment

Primary outcomes

Numerical Rating Scale(NRS)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Silodosin (Wash-out) Placebo

Interventions/Control_2

Placebo (Wash-out) Silodosin

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

Men who are not disabled in ejaculating
Men who are not disabled in achieving an orgasm
Men who can refrain from drinking alcohol before ejaculation

Key exclusion criteria

Men who are taking alpha adrenergic receptor blockade
Men who have received transurethral resection of prostate (TUR-P)
Men who have retrograde ejaculation
Men who have received retroperitoneal lymph node dissection (RPLND)
Men who have been diagnosed erectile dysfunction (ED)
Men who have been diagnosed diabetes

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Fumitaka Shimizu

Organization

Graduate school of medicine,
Juntendo University

Division name

Department of Urology

Zip code


Address

2-1-1, Hongo, Bunkyo-ku, Tokyo,113-8421 Japan

TEL

03-5802-1227

Email



Public contact

Name of contact person

1st name
Middle name
Last name Fumitaka Shimizu

Organization

Graduate school of medicine, Juntendo University

Division name

Department of Urology

Zip code


Address


TEL


Homepage URL


Email

fshimizu-jua@umin.ac.jp


Sponsor or person

Institute

Graduate school of medicine,
Juntendo University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 09 Month 02 Day

Date of IRB


Anticipated trial start date

2007 Year 10 Month 01 Day

Last follow-up date

2008 Year 03 Month 01 Day

Date of closure to data entry

2008 Year 03 Month 01 Day

Date trial data considered complete

2008 Year 03 Month 01 Day

Date analysis concluded

2008 Year 04 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 09 Month 30 Day

Last modified on

2008 Year 04 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001007


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name